Orbimed Advisors - INNOVAGE HLDG CORP ownership

INNOVAGE HLDG CORP's ticker is INNV and the CUSIP is 45784A104. A total of 74 filers reported holding INNOVAGE HLDG CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of INNOVAGE HLDG CORP
ValueSharesWeighting
Q1 2021$5,158,000200,0000.05%
Other shareholders
INNOVAGE HLDG CORP shareholders Q2 2021
NameSharesValueWeighting ↓
SCW Capital Management, LP 413,516$1,811,0003.88%
Coliseum Capital Management, LLC 4,019,909$17,607,0001.56%
Zebra Capital Management LLC 66,368$291,0000.86%
WELCH CAPITAL PARTNERS LLC/NY 337,748$1,479,0000.46%
MAVERICK CAPITAL LTD 862,952$3,780,0000.09%
CAMBIAR INVESTORS LLC 307,694$1,348,0000.06%
State of Wyoming 11,231$49,0000.03%
ROYCE & ASSOCIATES LP 598,000$2,619,0000.03%
Gleason Group, Inc. 5,000$22,0000.01%
Edge Capital Group, LLC 15,000$66,0000.01%
View complete list of INNOVAGE HLDG CORP shareholders